Эпштейн Олег Ильич (RU),Тарасов Сергей Александрович (RU)
申请号：
RU2010133046/15
公开号：
RU2010133046A
申请日:
2010.08.06
申请国别(地区):
RU
年份:
2012
代理人:
摘要：
1. A method of inhibiting the production or enhancing elimination of a P24 protein, characterized in that an activated potentiated form of anti-CD4 antibodies is used. ! 2. The method according to claim 1, characterized in that the activated potentiated form of the anti-CD4 antibody is used in the form of an activated potentiated aqueous or aqueous-alcoholic solution, the activity of which is due to the process of multiple serial dilution of the matrix initial antibody solution in an aqueous or aqueous-alcoholic solvent in combination with external mechanical action - vertical shaking of each dilution. ! 3. The method according to claim 1 or 2, characterized in that the activated potentiated form of anti-CD4 antibodies is obtained by repeated serial dilution in combination with an external mechanical action - vertical shaking of each dilution from a matrix initial solution of antibodies to CD4 receptor with a concentration of 0.5 ÷ 5.0 mg / ml. ! 4. Means for inhibiting the production or enhancing elimination of the P24 protein, characterized in that it contains an activated potentiated form of anti-CD4 antibodies. ! 5. The tool according to claim 4, characterized in that the activated potentiated form of antibodies to CD4 is used in the form of an activated potentiated aqueous or aqueous-alcoholic solution, the activity of which is due to the process of multiple serial dilution of the matrix initial solution of antibodies in an aqueous or aqueous-alcoholic solvent in combination with external mechanical action - vertical shaking of each dilution. ! 6. The tool according to claim 4 or 5, characterized in that the activir1. Способ ингибирования продукции или усиления элиминации белка Р24, характеризующийся тем, что используют активированную потенцированную форму антител к CD4. ! 2. Способ по п.1, характеризующийся тем, что активированную потенцированную форму антител к CD4 используют в виде активированного потенцированного водного или водно-спиртового раствора, акти
